Registration Dossier

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

The skin sensitisation potential of Fyrolflex BDP was tested by the Magnusson & Kligman Maximisation method.

Fyrolflex BDP produced 0% sensitisation rate and was classified as non- sensitising.

Robust summary of the study is attached to the relevant endpoint records


Migrated from Short description of key information:
Robust summary of the study is attached to the relevant endpoint records

Justification for classification or non-classification